Newly Diagnosed Multiple Myeloma According To Imwg Criteria clinical trials

Explore recruiting newly diagnosed multiple myeloma according to imwg criteria clinical trials.

Also recruiting in Europe

Newly Diagnosed Multiple Myeloma According To Imwg Criteria trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, open-label, multicenter multi-cohort study to evaluate the efficacy and safety of anitocabtagene autoleucel in participants with newly diagnosed multiple myeloma

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Newly Diagnosed Multiple Myeloma According To Imwg Criteria trials by city

Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Toronto Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Vancouver Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Montreal Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Calgary Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Edmonton Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Ottawa Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Winnipeg Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Quebec City Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Hamilton Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Kitchener Newly Diagnosed Multiple Myeloma According To Imwg Criteria in London Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Halifax Newly Diagnosed Multiple Myeloma According To Imwg Criteria in New York Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Los Angeles Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Chicago Newly Diagnosed Multiple Myeloma According To Imwg Criteria in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease